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team (strongly agree-64%; agree-36%) and would recommend 
their care (strongly agree-75%; agree-25%). At PRE-Tx, 94% of the 
QS patients preferred to start RT within a day of CTSim compared 
to 16% of ConvProcess patients. The preference of ConvProcess 
patients changed significantly compared to QS patients at POST-
TX (p < 0.0001); 63% of ConvProcess and 96% of QS patients 
strongly agreed/agreed that given a choice they would prefer to 
start RT the next day after CTSim. The overall PSS for all patients 
were not different PRE- and POST-Tx (p = .8) and stress levels 
did not differ significantly between QS and ConvProcess patients 
(p = .76). For both groups, health was the most common stress. 
The IIRS for ConvProcess patients was 37.6 (PRE-TX) and 39 
(POST-TX), and for QS patients was 32 (PRE-TX) and 31.8 (POST-
TX); there was no difference in IIRS of ConvProcess and QS 
patients (p = .2). However, subscales of IIRS showed an increase 
in illness interference with aspects of Physical Recreation and 
Social relationships for ConvProcess patients compared to QS 
patients (p = .03). 
Conclusions: Women undergoing whole breast RT were satisfied 
with their care and preferred to start RT quickly following their 
CTSim. Their strongest stressor was health and their stress levels 
were unchanged at RT completion. Patient involvement and 
selection of RT timing may impact on their views of how 
treatment interferes with their lifestyle and social relationships. 
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Purpose:  Quality of Life (QoL) assessment in cancer clinical 
trials provides a more accurate evaluation of the well-being of 
individuals or groups of patients and of the benefits and side-
effects that may result from medical intervention. Therefore, 
our first task in dealing with cancer is to regain some sort of 
equilibrium which will include mental, physical and spiritual 
aspect of that individual by addressing these very real issues and 
creating a support system tailored to our patient and their needs.  
Methods and Materials: As part of a Dean’s summer project a 
survey was undertaken to facilitate a more complete description 
of the quality of life experience of patients with histological 
diagnosis of cancer undergoing external beam radiation as an 
outpatient at Allan Blair Cancer Centre, Regina, Canada. The 
questionnaires had two major components; depression and 
global QOL. The depression was measured by the Zung Self-
Rating Depression Scale which is a short self-administered survey 
to quantify the depression status of a patient.  
Results: That data indicated that only the variable of age was a 
significant predictor. A positive relationship was present 
indicating higher levels of depression when patients received 
chemotherapy or narcotics. Breast cancer patients rated quality 
of life, functional well-being significantly higher than lung 
cancer patients p > 0.05.Breast cancer patients also scored 
significantly lower on the measure of depression than lung cancer 
patients p > 0 .05.  
Conclusions: A significant relationship between the 
chemotherapy, narcotics use and QOL was found in our study. 
For clinicians, this means not only demonstrating that such data 
are clinically useful but also addressing the effect on clinic work 
flow, constrained resources for data collection and management, 
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Purpose: Respiratory motion management is used in breast 
radiotherapy to reduce dose to cardiac and pulmonary organs at 
risk or decrease required margins. Varian Real-time Position 
Management (RPM) is a common tool for gated and Deep 
Inspiration Breath Hold (DIBH) treatments in breast. The external 
marker block is typically placed between the xiphoid process and 
the umbilicus. However, block movement in this location may 
not be well correlated with the internal chest wall motion. Here, 
we examine the feasibility of placing the marker block directly 
on the breast/chest wall to improve the correlation between the 
target and external marker motion. 
Methods and Materials: Three primary concerns are considered: 
1) the bolusing effect of placing the marker block in the primary 
field; 2) amplitude accuracy with block positioning; and 3) 
correlation between the exterior surface position and internal 
motion.1) We determine the bolusing effect of the two-dot, six-
dot, and ‘hippo’ (TrueBeam) marker blocks for a 6 MV beam at 
perpendicular incidence (Gantry 0°) using a Markus ionization 
chamber. 2) When the marker block is placed on an intact breast, 
it may tilt in the lateral direction. We investigate the impact of 
tilt (0° to 50°) on detected motion amplitude of the two-dot and 
six-dot marker block systems. 3) An in-house edge detection code 
was used to extract internal chest wall and external surface 
contours on each frame of weekly during-treatment cine portal 
images on the medial field from 20 DIBH patients. A population-
based correlation study determines the external surface block 
location that best represents internal chest wall motion. 
Results: 1) At perpendicular beam incidence, all three marker 
blocks doubled the surface dose reading compared to the surface 
dose with no marker block. This is equivalent to approximately 
2.5 mm of bolus. Increasing beam obliquity is expected to 
increase this bolusing effect. 2) The RPM system overestimated 
the detected amplitude of the two-dot marker block when the 
block was tilted laterally: on average by 1 mm at 20°; 2.5 mm at 
30°; 5 mm at 40°; and 8 mm at 50°. The detected amplitude 
when using the six-dot marker block system was unaffected by 
lateral tilt. 3) Preliminary results using the cine portal image 
chest wall and surface contours suggest that positioning the 
marker block at the nipple line best represents central chest wall 
motion. 
Conclusions: Placing the RPM marker block on the breast/chest 
wall at the nipple line is expected to improve the correlation 
between the block movement and chest wall motion with a small 
impact on skin dose. The six-dot marker block system should be 
used for intact breast, as it is more robust to lateral tilting than 
the two-dot marker block system. A study of 24 left-sided breast 
patients using this block placement for DIBH treatments is 
currently underway at our centre. 
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Purpose: Amongst uncommon primary ocular tumours, choroidal 
melanoma represents the most common diagnosis. Our preferred 
treatment for juxtapapillary tumours has been stereotactic 
radiotherapy using the Cyberknife radiosurgery system. We aim 
to describe our immobilization system and quantify its 
reproducibility. 
Methods and Materials: Patients treated for choroidal melanoma 
were identified in our radiosurgery database. Patients were 
imaged at CT simulator with an in-house system which allows 
visual monitoring of the eye as the patient fixates a small target. 
All patients were re-imaged at least once prior to and/or during 
radiotherapy. The patients were treated on the Cyberknife 
system, 60 Gy in 10 daily fractions, using skull tracking in 
conjunction with our visual monitoring system. In order to 
